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"The principal facts concerning this subject are that 
normal sera may agglutinate or hemolyze the erythrocytes of 
other individuals of the same species, and that on injection 
of red cells antibodies may be formed which by agglutination 
or hemolysis differentiate the blood corpuscles of various 
individuals within a species." 
---Karl Landsteiner, 
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INTRODUCTION 
This paper is in two parts. Part I is a review of the 
activities and experience of the Blood Transfusion Service of 
Yale-New Haven Hospital. Since 1961 the service has kept accurate 
records of its experience in antibody detection and identification 
by serological methods. With a record of five full years avail¬ 
able it seemed appropriate to make a careful analytical review. 
It was hoped that such a review might reveal something more about 
the frequency of antibody occurrence, might make possible some 
predictions based on the experience of the service, and might 
make it possible to compare the experience of this service with 
that of other blood transfusion services. 
With these general aims the review was undertaken. During 
the course of the analysis it became clear that while the records 
showed how many antibodies the service had detected and identified 
they did not show how many antibodies had been caused by 
transfusions administered in this hospital. There had never 
been a systematic follow-up of a random group of transfused 
patients to determine how many of them developed irregular blood 
group antibodies in response to the antigenic stimulus of 
therapeutic transfusion. A review of the literature indicated 
that no other transfusion service had done such a study either. 
Asked as simply as possible, the question was, "What are the 
chances that a patient who is transfused in this hospital will 
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develop an irregular blood group antibody as a result of the 
transfusion?u Part II of this paper describes the experiment 
that was designed and carried out in the hope of finding an 
answer to this question. 
I. THE BLOOD TRANSFUSION SERVICE, 1961-1965 
Donors and Patients 
Donors 
Bank blood used in Connecticut is given to hospitals by 
the Connecticut Red Cross. The Red Cross collects the blood 
from volunteer donors who are resident in the state and 
distribute!it through its central facility in Hartford. The 
volunteer donors meet the standards of the American Association 
of Blood Banks (21,28) but are otherwise unselected as to age, 
sex or race. There are no commercial blood banks in this state. 
The assumption is that a donor who cannot profit from his 
donation will be less likely to misrepresent the state of his 
health than will a person who is selling his blood for cash. 
The implication for the patient population is that there will be 
a low incidence of serum hepatitis associated with transfusion. 
In general, the donor bloods used in this hospital are 
supplied by the Connecticut Red Cross. However, a certain 
number of donor bloods are drawn in this hospital, either for 
open heart surgery or to meet emergency needs. Except for a few 
very rare blood types these bloods too are given by volunteers 
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who are unselected except that they must meet the standards of 
the American Association of Blood Banks. 
Nonobstetrical Hospital Patients 
These are adult and pediatric medical and surgical patients 
whose blood is typed and tested for antibodies in the expectation 
that they will be transfused. Typing and antibody detection 
testing is not routinely performed on the blood of every patient 
admitted to this hospital. 
Obstetrical Patients 
The blood of every pregnant woman is t3rped and tested for 
the presence of irregular blood group antibodies when she is 
first seen in the obstetrical clinic of this hospital. 
Patients in Other Hospitals 
When asked to do so, this service tries to assist other 
hospitals in this region with,occasional difficult crossmatches 
or with identification of obscure antibodies. 
Antibody Detection Test 
All donor bloods, whether received from the Connecticut Red 
.Cross or drawn in this hospital, and the bloods of all patients 
who are considered for transfusion therapy are subjected to an 
antibody detection test. Throughout most of the period under 
consideration the antibody detection method was constant. It 
consisted of tests performed in a saline medium and in an 
albumin-enriched saline medium to which antihuman globulin was 
added: 
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Saline method. One drop of the serum to be screened is 
put into a 10x75 mm test tube and one drop of a 4% suspension 
in saline of this service’s Reagent Red Blood Cells (21,28) 
described in Part II is added. The tube is centrifuged for 10 
seconds at 3,400 rpm in a MacBick Hemofug^?)and examined 
macroscopically for agglutination. The tube is then allowed 
to stand at room temperature for 15 minutes. It is then again 
centrifuged for 10 seconds at 3,400 rpm and examined 
macroscopically for agglutination. 
Albumin-antiglobulin method. One drop of the serum to 
be screened is put into a 10x75 mm test tube. One drop of a 
4% suspension in saline of Reagent Red Blood Cells and two 
drops of a 22% solution of bovine albumin are added to the 
tube. The tube is then centrifuged for 10 seconds and examined 
macroscopically for agglutination. The tube is then placed 
in a 37° C. water bath for 15 minutes, centrifuged for 10 
seconds and examined macroscopically. The cells are then 
washed three times with saline. After the last wash a drop 
of antihuman globulin (Coombs serum) is added to the cells and 
the suspension is thoroughly mixed. The tube is then 
centrifuged for 10 seconds and examined macroscopically and 
microscopically. 
In mid-1965 the saline method was eliminated from the 
antibody detection procedure and a proteolytic enzyme method 
was instituted: 
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Bnzyme method. One drop of the serum to be screened is 
put into a 10x75 mm test tube and one drop of a suspension 
in saline of Reagent Red Blood Cells is added. Next a drop of 
commercial proteolytic enzyme preparation (Spectrazyme) is 
added, and the tube is allowed to stand three minutes at room 
temperature. It is then centrifuged for 10 seconds and 
examined macroscopically for agglutination. The tube is then 
placed in the 37° C. water bath and allowed to remain there 
until the albumin-antiglobulin tube procedure has been 
completed (about 20 minutes). It is then centrifuged for 10 
seconds and examined macroscopically. 
Results 
Transfusions and Recipients 
During the five years covered by this review, 54,771 
units of blood and blood products were administered to 14,783 
patients for an average of 3.70 units per transfused patient 
over the entire five-year period. The figures for each year 
are shown in Table 1, and the same data are shown graphically 
in Figure 1. 
Table 2 shows the per cent of each year's admissions that 
received transfusions and compares the annual figures with the 
mean per cent for the five-year period. As presented, the 
differences in percentages are highly significant. It must 
be pointed out, however, that the table compares the number of 
patients transfused in calendar years with the number of 
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patients admitted ih fiscal years. This is not completely 
accurate, but it is felt to be a justifiable approximation upon 
which to base general conclusions. 
There is an overall upward trend in the number of 
transfusions, the number of recipients and the percentage of 
patients transfused from 1961 to 1965. The number of units 
administered was 9,971 in 1961 and was 11,785 in 1965, an 
increase of 18$ from the beginning to the end of the period 
under study. The number of recipients was 2,662 in 1961 and 
5,215 in 1965, an increase of 21$ from the beginning to the 
end of the period under study. In fiscal 1961 there were 28,459 
admissions and in fiscal 1965 there were 50,244 admissions, an 
increase of 6.4$ This upward trend, however, is not an 
unbroken one -- there were fewer recipients In 1964 than in 
1965, there were fewer transfusions given in 1965 than in 
1962, and a smaller percentage of patients was transfused in 
1964 than in 1965. 
Deliveries 
Pregnancy is the other great source of sensitization to 
blood group factors with the resultant production of 
circulating irregular blood group antibodies. An insignifi¬ 
cant number of the women who deliver in this hospital have ever 
been transfused, so that for analytical purposes the occurrence 
of antibodies in obstetrical patients can be compared with the 
total number of deliveries. The number of deliveries in the 
years under study is shown in Table 5, A total of 24,876 
babies was delivered in the five-year period. 
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TRANSFUSIONS and RECIPIENTS 
1 961 1 962 1963 1 964 1965 Total 
Transfusions 9,971 10,886 10,860 11,269 11,735 54,771 
Recipients 2,662 3,000 3,131 2,775 3,215 14,733 
Total no. of 
units given 
Total no. of 
3.74 3.63 3.47 4.06 3.66 3.70 
recipients 
Table 1 
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PERCENT OF PATIENTS TRANSFUSED 
1961 1962 1965 1964 1965 Total 
Patients 
transfused 2,662 5,000 5,151 2,775 5,215 14,783 
Patients not 
transfused 
25,777 25,548 26,000 26,730 27,029 131,134 
Patients 
admitted* 
23,459 28,548 29,151 29,555 50,244 145,917 
% transfused 9.56 10.51 10.75 9.59 1 0.65 10.13 
r2 
(3) - 61.2294 P « 0.001 
TABLE 2 
Statistical analysis by Dr, Paul S, 
Anderson,Jr., Department of Epidemiology 
and Public Health, Yale University School 
of Medicine. 
* Admission figures are for the hospital's fiscal year, which 
ends September DO. All other data in this paper are for the 
calendar years. 
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Numbers of Antibodies Identified 
During the period under review the Blood Transfusion 
Service identified a total of 1,057 antibodies.* Table 4 shows 
the distribution of these antibodies by years and according to 
the categories of the persons in whose serums they were found. 
Table 5 is a complete list of the antibodies, arranged according 
to specificity and frequency of occurrence. Over the entire 
five-year period 25% of the identified antibodies were found 
in donor bloods, 38% were found in the serums of nonobstetrical 
patients in this hospital, 32% were found in the serums of 
obstetrical patients in this hospital and 5% were found in 
serums studied for other hospitals. 
Table 6 shows the rate of identification of antibodies in 
the various categories -- donor bloods, nonobstetrical 
transfused patients in this hospital and obstetrical patients 
in this hospital. In each category the overall trend is upward; 
that is, there is a general increase in the rate of antibody 
identification between 1961 aid 1985. In 1965* however, the rate 
of antibody identification dropped slightly from the 1964 level 
in all categories. Figure 2 shows these data graphically. 
Frequency of Various Antibodies 
Table 7 shows, for each of the years under consideration, 
the frequency of each of the six most commonly identified 
antibodies -- D, Lea, K, C+D, P, and E. Taken together, these 
antibodies constitute 83% of all the antibodies identified in 
* This figure represents only identified antibodies; it does 
not include nonspecific cold agglutinins and it does not 
include nonsensical results with panels of red cells. 
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NUMBERS OF ANTIBODIES IDENTIFIED 
1961 1962 1963 1964 1965 Total % 
Donor Bloods 1 4 56 49 74 74 267 25 
Nonobstetrical 
Hospital 
Patients 18 33 95 130 120 396 38 
Obstetrical 
Patients 33 73 36 105 95 342 32 
0 tlier Hospitals 9 8 13 8 14 52 5 
TOTAL 74 170 193 317 303 1,057 100 
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ANTIBODIES IDENTIFIED 
196l - 1965_ 
ANTIBODY 1961 1962 1963 1964 1965 Total 
D 44 89 91 107 91 422 
Lea 3 20 23 55 34 135 
K 5 17 22 33 22 99 
C+D 3 1 2 14 20 33 82 
P 2 2 1 38 29 72 
E 5 7 16 13 20 63 
Fya 2 7 7 6 9 31 
c 0 8 3 6 5 22 
Leb 0 0 2 7 8 17 
M 2 2 3 5 4 1 6 
Lea+Le° 0 1 0 4 9 14 
C 0 0 2 4 3 9 
e 2 0 2 1 1 6 
S+K 0 0 1 2 3 6 
c+E 0 0 0 1 4 5 
C+D+E 0 1 0 1 3 5 
D+E 0 1 2 1 0 4 
Jka 0 1 2 0 0 3 
D+K 1 0 0 1 1 3 
Jkb 0 1 0 0 1 2 
Gw 1 0 0 1 0 2 
C+D+Fya 0 1 0 0 1 2 
M+K 0 0 0 0 2 2 
G+ © 0 0 0 0 2 2 
S 0 0 0 1 1 2 
N 0 0 0 1 1 2 
Cw+E 0 0 0 0 2 2 
c+E+Fya 1 0 0 0 0 1 















c+e 0 0 0 1 0 1 
c+Jka 0 0 0 0 1 1 
G+E 1 0 0 0 0 1 
C+K 0 0 0 1 0 1 
C+D+K 0 0 0 0 1 1 
D+Leb 0 0 0 0 1 1 
D+Fya 0 0 0 0 1 1 
D+P 0 0 0 0 1 1 
Bia 1 0 0 0 0 1 
M+P 0 0 0 1 0 1 
E+Fya 0 0 0 1 0 1 
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Table 5 (cont'd) 
ANTIBODY 1961 1962 1963 1964 1965 Total 
K+Kw 0 0 0 0 1 1 
L+Lua 0 0 0 0 1 1 
0(H)+P 0 0 0 0 1 1 
Dua 0 0 1 0 0 1 
Kw 0 0 1 0 0 1 
Jka+P 0 0 0 1 0 1 
X+Lea 0 0 0 1 0 1 
Wra 0 0 0 0 1 1 
Lub 0 0 0 0 1 1 
K+Fya+Lua 0 0 0 0 1 1 
hr»s 1 0 0 0 0 1 
74 170 193 317 303 1057 
TABLE 5 
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the period under review, Anti-D, expectedly, is by far the 
most frequently occurring antibody. But it ranges from a 
high of 59$ of all antibodies identified by the service in 
1961 to a low of 30$ of all antibodies identified by the 
service in 1965* This percentage decline is offset by absolute 
or percentage increases in others of the most commonly 
identified antibodies, particularly anti-Le J, anti-P and 
anti-G+D. Figure 3 shows graphically the percentage of each 
year’s total antibody yield that was represented by each of 
the six commonest antibodies, Anti-D, of course, towers over 
the rest. But comparison of the percentage of anti-D in each 
year’s antibody total with the combined percentages of the 
next five reveals a clear reciprocal relationship (Figure 4), 
Comparison With What Others Have Found. 
Little data has been published that will allow comparison 
of the experience of this service with that of other transfusion 
services. Reports of antibody occurrence have been published 
(5,8,12,13,14,15>17»18,19»20), hut virtually all of them deal 
with selected populations. Myhre et al (27) have reported on 
the incidence of irregular antibodies in the serums of blood 
donors, and the experience of this service may be compared with 
the experience of Myhre’s group, at least as far as donor 
bloods are concerned. Table 8 shows the frequency in donor 
bloods of the six commonest antibodies identified by this 
service in each of the years under review. Taken together, 
these six antibodies constitute 83$ of the antibodies 
identified by this service in donor bloods during the period 
under review and 88$ of the antibodies identified in donor 
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ANTI-D AND THE NEXT FIVE COMMONEST ANTIBODIES 
60 
20 





DONOR BLOODS ONLY 
1961 1962 1963 1 964 1965 Total qfA Myhre#% 
D 8 33 24 17 26 108 40 37 
t a Le 1 6 3 10 7 27 10 4 
K 1 4 4 8 4 21 8 12 
C+D 0 4 5 7 8 24 9 25 
P 1 0 1 18 13 33 1 2 1 











222 83 88 
TABLE 8 
* The Myhre group (27) found that 0,34$ of its donor bloods 
contained isoimmune antibodies; the Yale-New Haven 
service found that 0.49^ of its donor bloods contained 
isoimmune antibodies; as these overall figures are 
similar, it is felt that the percentages in the last 
two columns of this table are legitimately comparable. 
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bloods in the My lire et al study. For comparison purposes the 
' last two columns of the table are the interesting ones. 
Childers et al (31) tested 19,296 blood donors at 
Southwest Blood Banks, Inc., Scottsdale, Arizona, They found 
identifiable irregular isohemagglutinins in 2.J6% of this 
group, but only 0.62% had titers of 32 or greater. 
Smith et al (32) studied 12,297 obstetrical patients for 
irregular blood group antibodies. They found 173 anti-D and 
85 specific irregular antibodies, for a total of 258 specific 
antibodies. This calculates out to an occurrence rate of 
2,1 antibodies per hundred patients studied. 
Conclusions 
Transfusions and Recipients 
During the entire five-year period an average of 3.70 
units was given to each patient who was transfused. The 
annual figures vary only slightly from the five-year average, 
so that in general the number of units given to each patient 
has stayed constant throughout the period of review. 
From 1961 to 1965, while the total number of units 
administered increased by 18% and the total number of recipient 
increased by 21%, the number of hospital admissions increased 
by only about 6%. Thus it would appear at first glance that 
the therapeutic use of blood in this hospital is increasing 
about three times as fast as the number of admissions to the 
hospital. In fact the situation is not that simple. Table 
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2 compares the per cent of each year’s admissions that was 
transfused with the mean for the five-year period and shows 
that the differences are highly significant. But because 
the per cent of patients transfused did not increase each year, 
it is impossible to conclude with certainty that the use of 
transfusion therapy is increasing more rapidly than the 
number of admissions. This conclusion is suggested, however, 
and the question will be settled by the data of the next few 
years. 
Numbers of Antibodies Identified 
On the average, \yf> of the donor bloods collected by the 
Connecticut Red Cross are from repeat donors; that is, from 
persons who have donated blood at some other time in the past. 
Blood from donors who are known to have circulating 
irregular blood group antibodies is not shipped to the 
hospitals. Nonetheless, 25% of all antibodies identified by 
this service were found in donor bloods. It is clear from 
this figure that a blood transfusion service must screen donor 
bloods as carefully as it tests the blood of patients who are 
to receive transfusions. This careful testing of donor bloods 
for antibody has two aims — first, it prevents transfusion 
reactions that might occur as the result of action of donor 
antibody on recipient red cells; second, it is a method of 
identifying and removing from the donor pool those persons 
whose blood contains circulating antibody. Furthermore, 
services that perform careful antibody detection tests on dmor 
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bloods are, in the opinion of most authorities, able to 
eliminate the minor crossmatch from their compatibility testing 
procedures (21,29). 
The figures for the rates of antibody identification in 
the various groups are shorn in Table 6. The materials and 
methods now in use by this service were instituted in 1961, 
The general increase in the rate of antibody identification 
from 1961 to 1964 probably reflects the increasing technical 
skill of the service during this time rather than any change 
in the nature of the patients and donors. It seems likely 
that the figures for 1964 and 1965 are more suggestive of what 
the service can expect in the future than are the figures from 
the earlier years. Thus it seems to fair to predict that in 
the next few years: 
1) about 0,6% of the donor bloods received by this 
service will contain isoimmune antibodies; 
2) about 2%, of the women who deliver children in 
this hospital will have circulating isoimmune antibodies; 
3) about 4% of the nonobstetrical hospital patients 
who receive transfusions in this hospital will have 
circulating isoimmune antibodies either before or after 
transfusion. 
Frequency of Various Antibodies 
Figure 4 shows graphically that anti-D represents a 
shrinking proportion of all antibodies identified by the 
service as other less common antibodies represent a growing 
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percentage. This was particularly true in the 3^ears 1961-1963 
and as in the matter of the rate of antibody identification 
probably reflects the increasing technical skill of the 
service. In this case the increasing skill shows itself as 
increasingly frequent identification of less common antibodies. 
In this regard, two specific points deserve special comments. 
First, the frequency of anti-Lea declined from \’J% in 1964 to 11 % 
in 1965 (Table 7)• It was in mid-1965 that the room temperature 
saline method was discontinued by the service and the 
proteolytic enzyme method was begun, Anti-Le is maximally 
reactive in a saline medium at room temperature; it seems 
reasonable that the decreased frequency reflects the elimination 
from the antibody detection test of the medium in which this 
antibody is most highly reactive. Second, It is worthy of note 
that the decreasing frequency of anti-D Is partially offset by 
an increasing frequency of anti-C+D. Anti-D is a more highly 
reactive than anti-C. It is probable that until the service had 
achieved a considerable skill the active anti-D was found but 
the anti-C activity was overlooked. 
Figures for 1964 and 1965 are quite similar and probably 
indicate what the service’s experience will be In the future. 
Thus it is probable that in the next few years: 
1) the six commonest antibodies -- D, Lea, K, G*D, P, 
and E — will constitute about 80$ of all antibodies identified 
by the service; 
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2) anti-D will constitute about 32% of all antibodies 
identified; 
3) the next five commonest antibodies will make up 
about 50% of all antibodies identified. 
Comparison With What Others Have ftound 
Both for Myhre’s group in its four-year study and for this 
service in its five-year review anti-D makes up about 40% of all 
antibodies identified in donor bloods. In other instances the 
experience of the two groups varies widely. In particular, 
this service finds a larger percentage of anti-Lea and anti~P 
among its donors than the Myhre et al group found in its donors. 
Ten percent of the antibodies identified by this service in 
donor bloods were anti-Lea, compared with 4% for the Myhre 
group. And 12% of the antibodies found by this service In donor 
bloods were anti-P, compared with 1% for the Myhre group. The 
reason for this difference Is not clear. It may reflect some 
technical difference that is not apparent, for both these 
antibodies should be active in the screening methods the Myhre 
group describes. 
The Myhre group found that 0.34% of its donor bloods 
contained isoimmune antibodies. This service found isoimmune 
antibodies in 0.49% of Its donor bloods. These figures are 
comparable. Childers et al of the Scottsdale group have 
reported an occurrence rate of Identifiable irregular antibodies 
that is about four times the rate achieved by this service in 
its best years. 
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The Smith group’s rate of antibody occurrence in 
obstetrical patients is very close to the experience of this 
service during the last two years of the period under survey. 
This tends both to confirm the findings of this service and to 
reaffirm the inference drawn elsewhere that the service's 
increasing rate of antibody identification in the years 1961 
through 1963 represented in part its increasing skill in 
antibody identification. 
Summary 
During the five years under review, about 12$ of the 
nonobstetrlcal patients in this hospital received blood or 
blood products. Each patient who was transfused received an 
average of 3.70 units. From the first year of the five-year 
review period to the last the amount of blood and blood products 
given to patients increased by 18$ and the number of patients 
receiving transfusions increased by 21$ while the number of 
admissions increased by 6.4$. It is probable but not yet 
statistically certain that an increasing proportion of patients 
is receiving transfusion therapy. 
During this period it was found that 0.49$ of donor bloods 
contemned antibodies, the bloods of 1.35$ of obstetrical 
patients contained antibodies and the bloods of 2.7$ of non- 
obstetrical transfused hospital patients contained antibodies. 
The six most common antibodies constituted 83$ of all antibodies 
identified. 
Certain predictions are made on the basis of the five-year 
experience of this service and certain comparisons are made with 
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the findings of Myhre et al in the Milwaukee Blood Center, 
and with the findings of others. 
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II. THE OCCURRENCE OF IRREGULAR BLOOD GROUP ANTIBODIES 
AFTER TRANSFUSION 
Discovery of the ABO system and its naturally occurring 
antibodies by Landsteiner (1,2) in 1900 made widespread use of 
transfusion therapy possible. The discovery by Ehrlich and 
Morgenroth (3), made shortly thereafter, that erythrocytes 
from a goat when Injected into a second goat will stimulate 
the second to make a hemolysin laid the basis for the 
discovery of the other blood group systems and for all current 
work in isoimmunization. 
After Landsteiner’s discovery,of the ABO system more than 
twenty-five years elapsed before another system was discovered. 
Landsteiner and Levine (22) injected human red cells into 
rabbits and with the antibodies thus produced they identified 
the MN system in 1928. Landsteiner and Wiener (23,24) injected 
rhesus monkey red cells into rabbits and obtained antibodies 
that reacted with both human and monkey cells. Using these 
serums they identified the Rh system in 1940, Since 1940 eight 
other systems have been discovered, so that now one must contend 
with 11 major systems containing more than 100 known blood 
factors. Any one of these factors may stimulate antibody 
formation. And every antibody is a potential hazard to the 
patient in whose blood it circulates. To a woman in the child- 
bearing years an antibody means the danger of hemolytic disease 
in her children. To any patient who needs transfusion, a 
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circulating antibody means increased difficulty in finding 
compatible blood. And there is the subtler problem of the 
patient who is sensitized to one of the blood factors but in 
whom the antibody is not detectable serologically, either 
because it never reached detectable levels or because it has 
declined to a level at which it is no longer detectable. In 
either case this patient is peculiarly liable to suffer a 
delayed hemolytic transfusion reaction. 
For these reasons it has become important to know some¬ 
thing about the frequency of isoimmunization after transfusion. 
A number of investigators have worked on this problem and have 
brought a number of different methods to bear on it. Most of 
the studies (4,5,6,7,8,9,10) have dealt with selected 
populations. Some (11,12,13,14) have been based upon deliberate 
attempts to sensitize volunteers by Injecting into them small 
quantities of incompatible red cells. Some studies have 
tested for the frequency of sensitization as a result of 
transfusion with specific red blood cell factors -~ e.g„, 
Rh (15,l6) or Kell (17). Others have been limited to open 
heart surgery patients, who receive massive transfusions (18, 
19,20). 
The purpose of this study was to follow a random group 
of patients who were transfused under clinical conditions 
because they needed transfusions, and to find out how many of 
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Patients 
As far as practicable this study included all patients on 
the University service, medical and surgical, who received 
transfusions during a one-month period beginning July 14, 
1964, and ending August 13, 1964, except: 
1) those under 15 years of age and 
2) those discharged before the fifth day after 
transfusion. 
There were 111 patients brought into the study. They received 
a total of 376 units of blood. Individuals received from one 
to 22 units, for an average of 2.96 units per patient. All 
blood given these patients was ABQ-compatible, Rh0(D)~ 
compatible and was found to be free of antibody when tested by 
the Blood Transfusion Serviced usual methods (these methods 
are described in Part I of this paper). 
In addition to the Blood Transfusion Service*s routine 
pretransfusion testing, a pretransfusion sample of the patient*s 
serum was tested for antibodies by the method of this study, 
which is described below. Blood samples were then drawn from 
each of these patients each five days after transfusion as long 
as they stayed in the hospital and an effort was ms.de to secure 
a follow-up sample from each patient about a year after 
transfusion; that is, at some time during the months of July 
or August 1965. All these samples were tested for antibody by 
the methods of this study. 
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The antibody detection method used in this study consists 
of testing the ability of the patients® serums to agglutinate 
the Blood Transfusion Service’s Reagent Red Blood Cells (21, 
28) under various conditions: 1) in a saline medium at room 
o 
temperature, 2) in a saline medium at 4 C., 3) in a saline 
medium at 37° C. to which proteolytic enzyme is added, 4) in 
an albumin-enriched saline medium after 30 minutes* incubation 
o . 
at 37 C., and 5) by the indirect antiglobulin method. 
Seven members of the house and laboratory staffs make up 
the donor pool for the service’s Reagent Red Blood Cells, 
Each batch of Reagent Red Blood Cells contains red cells from 
three of these seven donors, so that each required antigenic 
determinant is present on more than thirty per cent of the cells 
in the test suspension. Blood is drawn from the donors into 
modified Alsever’s solution (30), The blood from all three 
donors is then mixed, and the mixture is stored at 4° C. For 
daily use in the blood bank, small aliquots are withdrawn and 
are washed three times in normal saline. The antigenic deter¬ 
minants on the red cells of the various members of this donor 
pool are shorn in Table 9. 
The antibody detection test is conducted with a saline tube, 
an enzyme tube and an albumin-antiglobulin tube: 
Saline tube. One drop of the serum to be screened is put 
into a 10x75 mm test tube and one drop of a 4% suspension in 
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1 T“ T" 5 7 COMBINATIONS LACKINt 
0 0 0 0 0 0 0 1-2-3 None 
4 4 4 4 4 4 4 
0 •+ + 4 0 4 0 1-2-4 None 
+ 4 0 4 4 4 4 
4 4 + 4 4 4 4 1-2-6 None 
4 4 + 4 4 4 0 
4 0 0 4 4 4 4 2-3-4 None 
+ •1" 4 0 4 4 4 
+ + 4 4 4 0 0 2-3-6 None 
0 4 4 0 4 4 4 
0 + 4 4 4 0 0 2-3-7 None 
4 + 4 4 0 4 4 
0 4 0 0 4 0 0 2-4-5 None 
4 4 4 4 4 4 4 
0 0 + 4 0 4 0 2-4-6 None 
4 + 0 0 0 0 4 
0 4 + 4 4 4 4 2-4-7 None 
4 0 4 0 4 4 
0 0 0 0 0 0 2-5-6 None 
+ 4 4 4 4 4 
4 0 4 4 4 4 4 2-6-7 None 
4 4 4 4 4 4 4 
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saline of the service’s Reagent Red Blood Cells is added. 
The tube is allowed to stand for 20 minutes at room temperature. 
It is then centrifuged for 10 seconds at 3,400 rpm in a MacBick 
/gj 
Hemofuge^ and examined macroscopically for agglutination. The 
cells are then resuspended and the tube is refrigerated at 
4° C, for 20 minutes. Then it is again centrifuged for 10 
seconds and examined macroscopically. 
Enzyme tube, method #1. This method was used with all 
samples acquired while the patients were hospitalized. One 
drop of the serum to be tested, one drop of a 4% suspension in 
saline of Reagent Red Blood Cells and one drop of papain (pre¬ 
pared by Low’s method) are put into a 10x75 mm test tube. The 
tube is placed in a 37° C, water bath for 30 minutes, then 
centrifuged for 10 seconds at 3,400 rpm and examined 
macroscopically. 
Enzyme tube, method #2. This method was instituted in 
1965 and was used on all one-year follow-up serum samples. One 
drop of serum, one drop of suspension of Reagent Red Blood 
Cells and one drop of a commercial enzyme solution (Spectrazyme) 
are put into a 10x75 mm test tube. The tube is allowed to stand 
at room temperature for 3 minutes. It is then centrifuged and 
examined macroscopically. If there is no agglutination in the 
tube the cells are completely resuspended and the tube is 
placed in a 37° C. water bath for 10 minutes. It is then again 
centrifuged and examined macroscopically. 
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Albumin-antiglobulin tube. One drop of serum, one drop 
of 4$ suspension of Reagent Red Blood Cells and one drop of a 
22% solution of bovine albumin are placed into a 10x75 mm test 
tube and mixed thoroughly. The tube is then centrifuged and 
examined macroscopically. The cells are then resuspended and 
the tube is placed in a 57° C. water bath for 30 minutes, then 
again centrifuged and examined macroscopically. The cells are 
again resuspended and are washed three times with normal saline. 
A drop of antiglobulin serum (University of Pennsylvania) is 
added to the cells and the suspension is thoroughly mixed. 
The tube is then centrifuged for 10 seconds and examined for 
agglutination both macroscopically and microscopically. 
All serums that gave positive agglutination reactions in 
any of the three tubes were subjected to attempts at antibody 
identification. 
Antibody Identification 
The aatibody identification method used in this study 
consists of testing the ability of patients’ serums to 
agglutinate some but not all of the red blood cells supplied 
commercially by Spectra Biologicals, Inc., as the MTencell 
Panel.” Each serum that gave a positive agglutination reaction 
in the antibody detection test was tested against a "Tencell 
Panel” under the same conditions used in the antibody detection 
test: l) in a saline medium at room temperature, 2) in a saline 
medium at 4° C., 3) in a saline medium at 37° C. to which 
proteolytic enzyme Is added, 4) in an albumin-enriched saline 
medium after 30 minutes1 incubation at 37° C., and 5) by the 
indirect antiglobulin method. 
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The antibody identification test is conducted with a set 
of saline tubes, a set of enzyme tubes and a set of albumin- 
antiglobulin tubes; there are 12 tubes (10x75 mm) in each set: 
Saline set. One drop of the serum to be tested is put 
into each of the 12 tubes. To tube #1 Is added one drop of 
cell #1 of the "Tencell Panel," to tube #2 is added one drop of 
cell #2 of the "Tencell Panel," and so forth through tube #10. 
To tube #11 is added one drop of the patient's cells, washed 
and suspended in saline. To tube #12 is added a drop of the 
service's Reagent Red Blood Cells. The set is allowed to stand 
for 20 minutes at room temperature. It is then centrifuged for 
10 seconds at 3,400 rpm and examined macroscopically for 
agglutination. The cells are then resuspended; the set is 
refrigerated at 4° C. for 20 minutes and is again centrifuged 
for 10 seconds and examined macroscopically. 
Enzyme set, method #1. This method was used with all 
samples acquired while the patients were hospitalized. One 
drop of the serum to be tested is put into each of the 12 
tubes. Red cells are added to each of the tubes as described 
above. One drop of Low's papain is then added to each tube. 
The set is placed in a 37° 0. water bath for 30 minutes, then 
centrifuged for 10 seconds and examined macroscopically. 
Enzyme set, method #2, This method was instituted in 
1965 and was used on all one-year follow-up serum samples. One 
drop of the serum to be tested is put Into each of the 12 tubes. 
Red cells are added to each of the tubes as described above. One 
drop of Spectrazyme is then added to each tube. The set is 
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allowed to stand at room temperature for 3 minutes. It is 
then centrifuged and examined maeroscopically. If there is 
no agglutination in the tube the cells are completely 
resuspended and the set is placed in a 37° C. water bath for 
10 minutes. It is then again centrifuged and examined 
ma cro s copi cal'ly. 
Albumin-antiglobulin set. One drop of the serum to be 
tested is placed in each of the 12 tubes of the set. Red 
cells are added to each of the tubes as described above. One 
drop of a 22^ solution of bovine albumin is then added to each 
tube and the contents of each tube is mixed thoroughly. The 
set is then centrifuged and examined maeroscopically. The 
cells are then resuspended and the set is placed in a 37° C. 
water bath for 30 minutes, then again centrifuged and examined 
maeroscopically. The cells are again resuspended and are washed 
three times with normal saline. A drop of antiglobulin serum 
(University of Pennsylvania) is added to each tube and the 
suspensions are thoroughly mixed. The set is then centrifuged 
for 10 seconds and examined for agglutination both macroscopi- 
cally and microscopically. 
After all reactions have been run, antibody identification 
is made, if possible, by comparison of the agglutination 
results with the known antigenic determinants on the various 
red cells of the "Tencell Panel." 
Follow-up Procedure 
As long as each patient stayed in the hospital a blood 
sample was taken from him every five days. Practical considera- 
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tions forced some deviations from this five-day interval 
between posttransfusion serum samples, but on the whole it was 
maintained as a standard. The numbers of patients followed and 
the length of time for which they were followed are shown in 
Table 10. 
By the time of the one-year follow-up 39 (35/0 of the 111 
patients in the study had died. It was possible to secure 
one-year follow-up samples from 60 patients, representing 83^ 
of those who were still living. 
Results 
Before transfusion eight of the 111 patients in the study 
were found to have antibodies. Four were not identifiable by 
our methods, two were anti-K (Kell), and one was anti-RhQ(D), 
and one was anti-P. After transfusion, two patients developed 
antibodies while still hospitalized. One antibody was 
identified as an anti-M and the other as anti-c. A third 
patient was found to have an anti-K at the time of the one-year 
follow-up. 
Discussion 
Patient J.M. This 43-year-old white married man with a 
recent history of myocardial infaction and cerebral vascular 
accident suffered a pulmonary embolus and underwent emergency 
embolectomy at this hospital. His preoperative antibody 
detection test was negative. He had had no blood transfusions 
before operation. At operation he received 5 units of blood 
and he received three more during the first three days after 
operation. Six days after operation an antibody detection test 
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FOLLOW-UP of PATIENTS 
Number of Patients Duration of Posttransfusion Follow-up 
20 35 days 
6 30 tj 
10 25 
!l 
1 1 20 tl 
10 15 
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was negative. Ten days after operation an antibody detection 
test was positive and his antibody was identified as anti-M. 
The antibody titer was 128 using 22^ bovine albumin as diluent 
and following the method described for the albumin-antiglobulin 
tube in the antibody detection test. A year after operation 
the antibody detection test was again negative. 
Patient D.H. This 45-year-old married woman entered this 
hospital for the third time because of acute intestinal 
obstruction. On her first admission, in 1947, she underwent 
excision of an intervertebral disk with spinal fusion. Her 
chart shows that she received one unit of blood at operation. 
She had no other history of transfusion. At the time of her 
third admission an antibody detection test was weakly positive 
by the indirect antiglobulin method and in the enzyme tube. 
Testing against a "Tencell Panel" gave nonsensical results. 
The patient underwent decompressive colostomy and was dis¬ 
charged. A few weeks later, she was admitted to this hospital 
for the fourth time for laparotomy. She was found at operation 
to have carcinoma of the sigmoid colon and left colectomy was 
performed. She received three units of blood. Five days 
after operation an antibody detection test was weakly positive 
by the indirect antiglobulin method but negative in the enzyme 
tube. On the eighth postoperative day the antibody detection 
test was very strongly positive by the indirect antiglobulin 
method and in the enzyme tube. The antibody was identified as 
anti-c with an antiglobulin titer of 256 using 22% bovine albumin 
as diluent and following the albumin-antigbbuLan tube method. 
This patient was group AB, Rh0(D)-positive. Because of the 
rarity of compatible blood she was phlebotomized of one unit 
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before her discharge. This unit was stored and was returned 
to the patient*s circulation to replace blood lost at closure 
of her colostomy three weeks later. A year after her colectomy 
the antibody detection test was weakly positive by the 
antiglobulin method and negative in the saline and enzyme tubes. 
Tested against a '’Tencell Panel," her serum was found still to 
contain detectable levels of anti-c. Because 1) this patient 
received a transfusion in 194-7 at the time of her first 
admission, and 2) her antibody detection test was strongly 
positive 8 days after transfusion in 1964, this may have been 
a secondary response. 
Patient G-. D. This 44-year-old white married man with no 
history of previous transfusion underwent elective closure of 
a ventricular septal defect. He received 16 units of blood at 
and after operation,including those used to prime the disc 
oxygenator. The preoperative antibody detection test was 
negative. Five days after operation he developed nonspecific 
cold agglutinins, but otherwise the antibody detection test was 
normal up to and including the time of discharge 15 days after 
operation. A year after operation this man was found to have a 
weak anti-Kell. The titer was less than one using normal saline 
as diluent and adding one drop of 22^ bovine albumin to each 
tube. On the day before his discharge this patient had 
received two more units of blood, bringing his total exposure 
during this hospitalization to 18 units. It was possible to 
find and to type the donors of the two predischarge units -- 
one was Kell-positive and one Kell-negative. It seems 
reasonable that the patient was sensitized by the Kell-positive 
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predischarge unit, since the day before his discharge an 
antibody detection test had been negative, and he had received 
no transfusions for two weeks before that. 
In calculating the rate of antibody occurrence those 
patients whose serums were tested only twice before 
transfusion and five days afterward -- were excluded because 
it is extremely unlikely that antibody would reach serologi¬ 
cally detectable levels within five days after the first 
antigenic stimulus. The remaining 39 patients received a 
total of 332 units of blood, for an average of 3.7 units per 
patient. This is exactly equal to the average number of 
units given to each transfused patient over the five-year 
period reported on in Part I of this paper. Three of these 
patients (about 3$) developed antibodies after transfusion. 
Three antibodies were produced in response to the total 
stimulus of 332 units. This Is a rate of 0,009 antibodies 
per unit. Thus in this series of patients the chance of 
developing an irregular blood group antibody from a single 
transfusion was about 0.9%• 
Lostumbo et al (25) studied a group of 127 patients who 
underwent open heart surgery. These patients were exposed to 
a total antigenic stimulus of 3160 units of blood* Thirty 
specific antibodies were formed in response to this total 
antigenic stimulus (cold panagglutinins and nonspecific 
antibodies are omitted from this comparison because they were 
omitted from all Yale-New Haven data), for a rate of 0.0095 
antibodies per antigenic unit. In this group the chance of 
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developing an irregular blood group antibody from a single 
transfusion was about 0.95%. 
Conclusions 
Unfortunately it seemed necessary to eliminate from the 
study those 22 patients whose serums were tested for antibody 
only twice -- before transfusion and five days afterward. 
Nonetheless, the correlations between Part I and Part II of 
this study and between Part II and the work of others (4,25) 
tend to support the findings. 
About 3% of the patients studied in Part II made new 
antibodies after transfusion. This figure agrees fairly well 
with the finding in Part I during the period when the service 
had reached a fairly high level efficiency; that is, of 
patients who were transfused and who were expected to be 
transfused, 4.78% in 1964 and 3.73% in 1965 had isoimmune 
antibodies in their serums (Table 6). 
The 0.9% risk of developing an antibody as a result of a 
single transfusion is this series correlates very well with 
G-iblettfs calculated risk of 1% (4), and with the findings of 
Lostumbo et al (25). The suggestion here is that as transfused 
patients in this hospital receive an average of almost 4 units 
each, about 4% of them can be expected to develop antibodies. 
An incidental finding of great interest was that if one 
follows a random group of transfused patients for a year, at 
the end of that time 35% of them will be dead. 
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